Cite
HARVARD Citation
González-Fernández, Y. et al. (2018). Oral administration of edelfosine encapsulated lipid nanoparticles causes regression of lung metastases in pre-clinical models of osteosarcoma. Cancer letters. pp. 193-200. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
González-Fernández, Y. et al. (2018). Oral administration of edelfosine encapsulated lipid nanoparticles causes regression of lung metastases in pre-clinical models of osteosarcoma. Cancer letters. pp. 193-200. [Online].